Moderna Begins COVID Vaccine Study for Children
The first group of children have been vaccinated in Moderna’s latest phase of a pediatric Covid-19 vaccine trial. The trial called the ‘KidCOVE’ study will monitor 6,750 children in the U.S. and Canada between the ages of 6 months and 11 years old. It’s broken into two parts, in the first, different doses of the same vaccine are being tested…